Skip to main content
. 2018 Jan 12;9(1):309–315. doi: 10.1007/s13300-017-0360-6

Fig. 1.

Fig. 1

Age distribution of patients ≥ 65 years of age with type 2 diabetes initiating treatment with sitagliptin or a non-DPP-4i oral antihyperglycemic agent (OAHA)